Bank Of New York Mellon Corp Pa Vmed Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.41 - $18.6 $42,473 - $1.93 Million	103,595 New	103,595 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $34.65 $21,502 - $1.31 Million	37,724 Added 108.14%	72,609 $62,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $149,730 - $248,377	-176,154 Reduced 83.47%	34,885 $33,000
Q1 2022 May 11, 2022	SELL	$1.16 - $2.5 $104 - $225	-90 Reduced 0.04%	211,039 $278,000
Q4 2021 Feb 11, 2022	SELL	$2.46 - $8.74 $408,465 - $1.45 Million	-166,043 Reduced 44.02%	211,129 $519,000
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $99,485 - $183,170	19,507 Added 5.45%	377,172 $3.22 Million
Q2 2021 Aug 11, 2021	BUY	$3.95 - $6.88 $766,189 - $1.33 Million	193,972 Added 118.5%	357,665 $2.29 Million
Q1 2021 May 13, 2021	BUY	$2.01 - $5.55 $96,029 - $265,156	47,776 Added 41.22%	163,693 $726,000
Q4 2020 Feb 09, 2021	BUY	$1.73 - $2.13 $60,979 - $75,078	35,248 Added 43.69%	115,917 $245,000
Q2 2020 Aug 12, 2020	BUY	$1.75 - $2.65 $141,170 - $213,772	80,669 New	80,669 $170,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.